Prelude Capital Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Prelude Capital Management’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200	Closed	-$4K	–	2283
2020 Q3	$4K	Buy	+200	New	+$2.84K	﹤0.01%	1611

Prelude Capital Management's AKCA Position: Q4 2020 in Review

Prelude Capital Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 30,618 shares — an estimated $555K sold.

Prelude Capital Management first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $555K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Prelude Capital Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Prelude Capital Management sold 30,618 Akcea Therapeutics Inc shares in Q4 2020, an estimated $555K.
Prelude Capital Management first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
Prelude Capital Management's Akcea Therapeutics Inc position peaked at $555K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.